-
Covid-19 vaccine: Covaxin, Covishield production to be ramped up to a billion doses
Bharat Biotech and Serum Institute of India have announced plans to ramp up production
-
Government panel to study feasibility of administering doses of different vaccines
Currently, doctors recommend both the doses of the Covid-19 vaccine should be from the same manufacturer
-
More pharma firms should be allowed to make vaccine: Nitin Gadkari
There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield
-
Miniscule bleeding, clotting events post Covishield inoculation in India
The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covis
-
Covaxin effective against India, UK coronavirus strains: Bharat Biotech
Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, Bharat Biotech noted that vaccination with Covaxin produced ne
-
Money9 Edit | Vaccination drive should not face any further roadblocks
The vaccination strategy has until now come up short and government should ensure that every stakeholder is on board for a successful implementation
-
Covid-19 Vaccination: National platform to track vaccine’s impact to be established soon
The vaccine tracker will be particularly important to monitor the impact of increasing the dosing schedule of Covishield.
-
Covid-19: Vaccination drive for 18-44 age group to begin in HP from May 17
All the eligible persons for vaccination will have to register themselves and schedule their appointment on the COWIN portal
-
Shortage of Covaxin stocks in Delhi leave people in 18-44 age group anxious
With Covaxin's stock finished, the Delhi government temporarily closed down around 100 centres administering the vaccine on Wednesday
-
Increase gap between two doses of Covishield to 12-16 weeks: Panel
The government panel also said that pregnant women may be offered the choice to take any vaccine
